[{"symbol": "RVMD", "publishedDate": "2026-01-13 07:38:00", "title": "First Look: Fed Probe, Bank Cap Shock, Gold Soars, Deals", "image": "https://images.financialmodelingprep.com/news/first-look-fed-probe-bank-cap-shock-gold-soars-20260113.png", "site": "gurufocus.com", "text": "Stock News DOJ subpoenas Fed chair spark backlash: Federal prosecutors served grand jury subpoenas to Jerome Powell over testimony on Fed HQ renovations, prompt", "url": "https://www.gurufocus.com/news/4107908/first-look-fed-probe-bank-cap-shock-gold-soars-deals"}, {"symbol": "RVMD", "publishedDate": "2026-01-12 17:26:01", "title": "Revolution Medicines, Inc. (RVMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript", "image": "https://images.financialmodelingprep.com/news/revolution-medicines-inc-rvmd-presents-at-44th-annual-jp-20260112.jpg", "site": "seekingalpha.com", "text": "Revolution Medicines, Inc. (RVMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript", "url": "https://seekingalpha.com/article/4858914-revolution-medicines-inc-rvmd-presents-at-44th-annual-j-p-morgan-healthcare-conference"}, {"symbol": "RVMD", "publishedDate": "2026-01-12 01:10:51", "title": "Revolution Medicines, Inc. (NASDAQ:RVMD) Given Average Rating of \u201cBuy\u201d by Analysts", "image": "https://images.financialmodelingprep.com/news/revolution-medicines-inc-nasdaqrvmd-given-average-rating-of-buy-20260112.png", "site": "defenseworld.net", "text": "Shares of Revolution Medicines, Inc. (NASDAQ: RVMD - Get Free Report) have been given an average rating of \"Buy\" by the eighteen research firms that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, thirteen have given a buy recommendation and four have assigned a strong buy", "url": "https://www.defenseworld.net/2026/01/12/revolution-medicines-inc-nasdaqrvmd-given-average-rating-of-buy-by-analysts.html"}, {"symbol": "RVMD", "publishedDate": "2026-01-11 08:01:45", "title": "Sandisk, Bloom Energy, And Oklo Are Among the Top 10 Large-Cap Gainers Last Week (Jan. 5-Jan. 9): Are the Others in Your Portfolio?", "image": "https://images.financialmodelingprep.com/news/sandisk-bloom-energy-and-oklo-are-among-the-top-20260111.jpeg", "site": "feeds.benzinga.com", "text": "Defense, AI power demand and deal-driven catalysts powered last week's top large-cap winners, led by sharp surges in RGC, RVMD and a cluster of defense and data-center energy plays.", "url": "https://www.benzinga.com/markets/equities/26/01/49831544/sandisk-bloom-energy-and-oklo-are-among-the-top-10-large-cap-gainers-last-week-jan-5-jan-9-are-t"}, {"symbol": "RVMD", "publishedDate": "2026-01-11 05:12:42", "title": "Jack Anders Sells 10,000 Shares of Revolution Medicines (NASDAQ:RVMD) Stock", "image": "https://images.financialmodelingprep.com/news/jack-anders-sells-10000-shares-of-revolution-medicines-nasdaqrvmd-20260111.png", "site": "defenseworld.net", "text": "Revolution Medicines, Inc. (NASDAQ: RVMD - Get Free Report) CFO Jack Anders sold 10,000 shares of Revolution Medicines stock in a transaction dated Wednesday, January 7th. The stock was sold at an average price of $98.00, for a total value of $980,000.00. Following the sale, the chief financial officer owned 108,065 shares in the company, valued", "url": "https://www.defenseworld.net/2026/01/11/jack-anders-sells-10000-shares-of-revolution-medicines-nasdaqrvmd-stock.html"}]